Compare · CERS vs VRSN
CERS vs VRSN
Side-by-side comparison of Cerus Corporation (CERS) and VeriSign Inc. (VRSN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and VRSN operate in EDP Services (Technology), so they compete in similar markets.
- VRSN is the larger of the two at $25.79B, about 49.5x CERS ($521.0M).
- Over the past year, CERS is up 74.0% and VRSN is up 1.9% - CERS leads by 72.1 points.
- CERS has been more active in the news (12 items in the past 4 weeks vs 9 for VRSN).
- VRSN has more recent analyst coverage (6 ratings vs 4 for CERS).
- Company
- Cerus Corporation
- VeriSign Inc.
- Price
- $2.58-1.15%
- $285.25+0.69%
- Market cap
- $521.0M
- $25.79B
- 1M return
- -1.53%
- -1.03%
- 1Y return
- +73.99%
- +1.91%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1997
- 1998
- News (4w)
- 12
- 9
- Recent ratings
- 4
- 6
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
VeriSign Inc.
VeriSign, Inc., together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. It enables the security, stability, and resiliency of internet infrastructure and services, including providing root zone maintainer services, operating two of the 13 internet root servers; and offering registration services and authoritative resolution for the .com and .net domains, which support global e-commerce. VeriSign, Inc. was incorporated in 1995 and is headquartered in Reston, Virginia.
Latest CERS
- Cerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation
- Cerus Corporation Closes New Debt Facility of Up to $110 Million
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
- Director Lucena Ann was granted 60,000 shares, increasing direct ownership by 35% to 232,284 units (SEC Form 4)
- Director Bjerkholt Eric was granted 60,000 shares, increasing direct ownership by 27% to 282,133 units (SEC Form 4)
- Director Nachtsheim Jami K was granted 60,000 shares, increasing direct ownership by 29% to 268,362 units (SEC Form 4)
- Chief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1.00% to 1,656,707 units (SEC Form 4)
- Director Witney Frank was granted 60,000 shares, increasing direct ownership by 21% to 340,059 units (SEC Form 4)
- Director Gregory Dean A. was granted 60,000 shares, increasing direct ownership by 69% to 146,725 units (SEC Form 4)
- Director Shan Hua was granted 60,000 shares, increasing direct ownership by 45% to 192,386 units (SEC Form 4)
Latest VRSN
- Exec. Chairman, Pres, & CEO Bidzos D James sold $981,646 worth of shares (3,300 units at $297.47), decreasing direct ownership by 0.75% to 439,339 units (SEC Form 4)
- EVP, Gen Counsel & Secretary Indelicarto Thomas C sold $146,725 worth of shares (500 units at $293.45), decreasing direct ownership by 1% to 37,051 units (SEC Form 4)
- Director Armstrong Courtney D bought $4,929 worth of shares (16 units at $305.81), increasing direct ownership by 0.26% to 885 units (SEC Form 4)
- Counterfeiters Stole an Estimated $500K From One Brand -- Now This NASDAQ Apparel Stock Is Building the AI That Fights Back
- VeriSign Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- EVP, Chief Financial Officer Calys John covered exercise/tax liability with 179 shares, decreasing direct ownership by 0.56% to 31,842 units (SEC Form 4)
- EVP, Gen Counsel & Secretary Indelicarto Thomas C covered exercise/tax liability with 706 shares, decreasing direct ownership by 2% to 37,496 units (SEC Form 4)
- EVP - Technology & CSO Mcpherson Danny R covered exercise/tax liability with 726 shares, decreasing direct ownership by 2% to 34,470 units (SEC Form 4)
- Exec. Chairman, Pres, & CEO Bidzos D James covered exercise/tax liability with 1,646 shares, decreasing direct ownership by 0.37% to 442,490 units (SEC Form 4)
- EVP - Technology & CSO Mcpherson Danny R sold $1,355,106 worth of shares (5,000 units at $271.02), decreasing direct ownership by 12% to 35,195 units (SEC Form 4)